Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1197 |
---|---|
Product Name | Anti-Human APP Abeta Recombinant Antibody(Solanezumab) |
Molecular Name | Solanezumab |
Alias | Anti-APP Abeta Recombinant Antibody, Research Grade Solanezumab |
CAS Number | 955085-14-0 |
Target | APP Abeta[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | WB, FuncS, IF, Neut, ELISA, FCM, IP |
Buffer | PBS, pH7.5 |
Background | Solanezumab (proposed INN, LY2062430[1]) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector[2] for patients with Alzheimer's disease.[3][4] The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials.[5] |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |